Cas:131379-39-0 4-ethoxy-4-oxobutylzinc bromide manufacturer & supplier

Chemical Name:4-ethoxy-4-oxobutylzinc bromide

CAS.NO:131379-39-0

Synonyms:4-Ethoxy-4-oxobutylzinc bromide solution 0.5 in THF;MFCD00671977;4-ethoxy-4-oxobutylzinc bromide solution

Molecular Formula:C₆H₁₁BrO₂Zn

Molecular Weight:260.43400

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:0.976 g/mL at 25ºC

Index of Refraction:

PSA:26.30000

Exact Mass:257.92300

LogP:2.14040

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3399 4.3/PG 2

Packing Group:

Contact us for information like 4-Ethoxy-4-oxobutylzinc bromide solution 0.5 in THF chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-ethoxy-4-oxobutylzinc bromide solution physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Ethoxy-4-oxobutylzinc bromide solution 0.5 in THF Use and application,MFCD00671977 technical grade,usp/ep/jp grade.

Related News: According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 4-ethoxy-4-oxobutylzinc bromide manufacturer First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 4-ethoxy-4-oxobutylzinc bromide supplier According to statistics, in the ten years from 2008 to 2017, a total of 13 China Class 1 small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China. 4-ethoxy-4-oxobutylzinc bromide vendor First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s. 4-ethoxy-4-oxobutylzinc bromide factory First up is Lilly, which reached all-time highs this week as attention turned to its once highly hyped donanemab, another anti-amyloid that saw a mixed bag of data back in March, with a slight win on one disease scale undermined by a failure on a more widely used measure of Alzheimer’s.